Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,263.37 +1,456.90 (+2.52%) CMC Crypto 200
1,279.12 +8.38 (+0.66%)
Eli Lilly and Company (LLYC.VI)
| Previous close | 724.10 |
| Open | 725.10 |
| Bid | 0.00 x N/A |
| Ask | 714.30 x N/A |
| Day's range | 712.90 - 725.10 |
| 52-week range | 386.40 - 736.00 |
| Volume | |
| Avg. volume | 12 |
| Market cap | 681.413B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 111.92 |
| EPS (TTM) | 6.37 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | 4.75 (0.66%) |
| Ex-dividend date | 14 Feb 2024 |
| 1y target est | N/A |
Yahoo FinanceNovo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
BenzingaWeight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S’s (NYSE:NVO) Wegovy and Eli Lilly And Co (NYSE:LLY) Mounjaro as initial supply shortages ease, a move driven by growing competition among retailers. The reduced prices at retailers like Simple Online Pharmacy, Mayfair Weight Loss Clinic, and London Slimming Clinic reflect the increasing demand for these weight-loss drugs. Simple Online Pharmacy, for instance, slashed the price of Mounjaro starter doses fro
ZacksEarnings Season: 3 Companies Boosting Guidance
Earnings season continues to chug along, with results from many companies already delivered. And concerning positivity, all three of these companies' report fit the criteria, lifting outlooks following the results.
